Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
4,912,339
-
Share change
-
+94,794
-
Total reported value
-
$7,662,384
-
Put/Call ratio
-
265%
-
Price per share
-
$1.56
-
Number of holders
-
46
-
Value change
-
+$48,360
-
Number of buys
-
21
-
Number of sells
-
20
Institutional Holders of Fortress Biotech, Inc. - COM NEW (FBIO) as of Q1 2025
As of 31 Mar 2025,
Fortress Biotech, Inc. - COM NEW (FBIO) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,912,339 shares.
The largest 10 holders included
Cambridge Investment Research Advisors, Inc., VANGUARD GROUP INC, PVG ASSET MANAGEMENT CORP, Nantahala Capital Management, LLC, Kestra Advisory Services, LLC, ENVESTNET ASSET MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, SHIKIAR ASSET MANAGEMENT INC, BlackRock, Inc., and HB Wealth Management, LLC.
This page lists
46
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.